Share URL
Embed chart view
StockViz
Atrys Health, S.A.
MCE:ATRY.MC
Sector
Location
Market Cap
USD 250.55 M
Share Price
USD 3.30
Avg Daily Volume
67,556
Change (1 day)
1.93%
Change (1 year)
-1.69%
Change (YTD)
-5.41%
Atrys Health, S.A. Share Price Year-To-Date (YTD) return on August 15, 2025: -5.41%
Atrys Health, S.A. Share Price Year-To-Date (YTD) return is -5.41% on August 15, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
Atrys Health, S.A. 52-week low Share Price is USD 4.07 on August 15, 2025, which is 23.33% above the current Share Price.
-
Atrys Health, S.A. 52-week low Share Price is USD 2.94 on August 15, 2025, which is -11.03% below the current Share Price.
-
Atrys Health, S.A. average Share Price for the last 52 weeks is USD 3.43.
Competitors
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Labcorp Holdings Inc.
USD 270.38
LH
-0.87
-0.32%
Sino Biopharmaceutical Limited
USD 1.00
1177.HK
+0.03
2.72%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.19
300832.SZ
+0.21
2.67%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.34
0874.HK
+0.02
0.70%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.94
600079.SS
-0.00
-0.04%
AddLife AB (publ)
USD 17.22
ALIF-B.ST
+0.03
0.20%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
+0.07
1.65%
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Labcorp Holdings Inc.
USD 270.38
LH
-0.87
-0.32%
Sino Biopharmaceutical Limited
USD 1.00
1177.HK
+0.03
2.72%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.19
300832.SZ
+0.21
2.67%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.34
0874.HK
+0.02
0.70%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.94
600079.SS
-0.00
-0.04%
AddLife AB (publ)
USD 17.22
ALIF-B.ST
+0.03
0.20%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
+0.07
1.65%
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%